1.525

2.87% -0.045

Alx Oncology Holdings Inc (ALXO)

Overview News Price History Option Chain Financials Discussions Forecast

Alx Oncology Holdings Inc stock is traded at $1.525, with a volume of 115.14K. It is down -2.87% in the last 24 hours and down -30.05% over the past month. ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Previous Close:

$1.57

Open:

$1.52

24h Volume:

115.14K

Relative Volume:

0.13

Market Cap:

$81.93M

Revenue:

Net Income/Loss:

$-151.16M

P/E Ratio:

-0.5135

EPS:

-2.97

Net Cash Flow:

$-130.08M

1W Performance:

-0.97%

1M Performance:

-30.05%

6M Performance:

+186.17%

1Y Performance:

+2.35%

1-Day Range:

$1.51

$1.5997

1-Week Range:

$1.49

$1.64

52-Week Range:

$0.404

$2.27

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name

Alx Oncology Holdings Inc

Sector

Healthcare (1138)

Industry

Biotechnology (633)

Phone

650-466-7125

Address

323 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

ALXO's Discussions on Twitter

Compare ALXO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALXO Alx Oncology Holdings Inc	1.53	84.08M	0	-151.16M	-130.08M	-2.97
VRTX Vertex Pharmaceuticals Inc	422.73	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.03	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	424.66	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	835.84	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	183.69	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-25	Upgrade	Jefferies	Hold → Buy
Dec-19-24	Downgrade	Jefferies	Buy → Hold
Mar-08-24	Downgrade	Stifel	Buy → Hold
Dec-08-23	Upgrade	Jefferies	Hold → Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Sep-30-21	Initiated	Stifel	Buy
May-05-21	Resumed	Credit Suisse	Outperform
Apr-26-21	Resumed	Credit Suisse	Outperform
Apr-06-21	Initiated	UBS	Buy
Feb-10-21	Initiated	H.C. Wainwright	Buy
Aug-11-20	Initiated	Cantor Fitzgerald	Overweight
Aug-11-20	Initiated	Credit Suisse	Outperform
Aug-11-20	Initiated	Jefferies	Buy
Aug-11-20	Initiated	Piper Sandler	Overweight

View All

Alx Oncology Holdings Inc Stock (ALXO) Latest News

12:48 PM

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Up 38.8% in October - MarketBeat

12:48 PM

07:05 AM

Analyzing recovery setups for ALX Oncology Holdings Inc. investorsWall Street Watch & Low Drawdown Investment Ideas - newser.com

07:05 AM

05:04 AM

Applying Wyckoff theory to ALX Oncology Holdings Inc. stockJuly 2025 Movers & AI Optimized Trade Strategies - newser.com

05:04 AM

04:46 AM

Can ALX Oncology Holdings Inc. hit a new high this monthJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com

04:46 AM

01:11 AM

Can ALX Oncology Holdings Inc. stock attract ESG capital inflowsEarnings Summary Report & Consistent Income Trade Recommendations - newser.com

01:11 AM

Nov 03, 2025

Key metrics from ALX Oncology Holdings Inc.’s quarterly data2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com

Nov 03, 2025

Building trade automation scripts for ALX Oncology Holdings Inc.Insider Selling & Short-Term Swing Trade Alerts - newser.com

Nov 03, 2025

Will ALX Oncology Holdings Inc. stock reach Wall Street targetsDollar Strength & High Yield Equity Trading Tips - newser.com

Nov 03, 2025

Is ALX Oncology Holdings Inc. stock attractive for hedge fundsSell Signal & Technical Pattern Recognition Alerts - newser.com

Nov 03, 2025

Statistical indicators supporting ALX Oncology Holdings Inc.’s strengthRisk Management & Free High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Will ALX Oncology Holdings Inc. continue its uptrendJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com

Nov 03, 2025

Is ALX Oncology Holdings Inc. stock a buy before product launches2025 Market Sentiment & Free Community Consensus Stock Picks - newser.com

Nov 03, 2025

How to build a dashboard for ALX Oncology Holdings Inc. stockJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Will ALX Oncology Holdings Inc. stock benefit from automationJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com

Nov 02, 2025